China Valsartan Market 2009-2018

About This Presentation
Title:

China Valsartan Market 2009-2018

Description:

Valsartan (Angiotan or Diovan) is an angiotensin II receptor antagonist (more commonly called an ARB, or angiotensin receptor blocker), with particularly high affinity for the type I (AT1) angiotensin receptor. In December 1996, Valsartan was approved by FDA. – PowerPoint PPT presentation

Number of Views:55

less

Transcript and Presenter's Notes

Title: China Valsartan Market 2009-2018


1
Investigation Report on China Valsartan Market,
2009-2018byResearch In China
  • Explore all reports for Life Sciences market
  • _at_ http//www.chinamarketresearchreports.com/cat/li
    fe-sciences.html .

2
Investigation Report on China Valsartan Market,
2009-2018
  • The collection of Life Sciences market research
    reports has a new addition of Investigation
    Report on China Valsartan Market, 2009-2018On
    chinamarketresearchreports.com. Valsartan
    (Angiotan or Diovan) is an angiotensin II
    receptor antagonist (more commonly called an ARB,
    or angiotensin receptor blocker), with
    particularly high affinity for the type I (AT1)
    angiotensin receptor. In December 1996, Valsartan
    was approved by FDA. In the US, UK and Australia,
    valsartan is marketed by Novartis under the trade
    name Diovan. In 1998, Valsartan was registered by
    Novartis in China with "Daiwen" as its brand
    name. After Valsartan, Novartis developed
    Valsartan compound preparation. In October 1997,
    valsartan/hydrochlorothiazide was approved by FDA
    with "CoDiovan" as its brand name New developed
    amlodipine/valsartan (Exforge) was also approved
    to the market.
  • There are many enterprises producing APIs and
    finished products of Valsartan. The market share
    of finished products is mainly occupied by
    Novartis, which is above 85 by sales value every
    year.
  • Inquire for discount _at_ http//www.chinamarketresea
    rchreports.com/contacts/inquiry.php?name114712

3
Investigation Report on China Valsartan Market,
2009-2018
  • In China, the number of hypertensive patients has
    exceeded 200 million so the market prospect of
    Valsartan is bright.
  • Through this report, the readers can acquire the
    following information
  • Market Share of Major Valsartan Manufacturers in
    Sampling Hospitals in China
  • Sales price of valsartan in hospital market in
    China
  • Major valsartan enterprises in China
  • Market share of valsartan by dosage form in
    hospital market in China
  • Prospect of China valsartan market
  • The Following Enterprises and People Are
    Recommended to Purchase This Report
  • Valsartan API and finished product manufacturers
  • Medical Institutions
  • Investors /research agencies focusing on
    valsartan market
  • Complete report is available _at_ http//www.chinamar
    ketresearchreports.com/114712.html

4
Investigation Report on China Valsartan Market,
2009-2018
  • Table of Contents
  • 1 Relevant Concepts of Valsartan1.1
    Indication1.2 Sales Status on the Global Market
  • 2 Market Overview of Valsartan in China2.1
    Patent Status2.2 Major Manufacturers2.3 Market
    Size
  • 3 Investigation on Sales Value of Valsartan in
    China, 2009-20133.1 Total Sales Value3.2 Sales
    Value by Region
  • 4 Investigation on Market Share of Major
    Valsartan Manufacturers in China, 2009-20134.1
    Market Share by Sales Value4.2 Market Share by
    Sales Volume
  • Inquire for discount _at_ http//www.chinamarketresea
    rchreports.com/contacts/inquiry.php?name114712

5
Investigation Report on China Valsartan Market,
2009-2018
  • 5 Investigation on Market Size of Valsartan by
    Dosage Form in China, 2009-20135.1 Market Share
    by Sales Value and Dosage Form5.2 Market Share
    by Sales Volume and Dosage Form
  • 6 Reference Price of Valsartan in Hospital Market
    in China, 20136.1 Tianda Group6.2 Livzon
    Pharmaceutical Factory of Livzon Group6.3
    Beijing Novartis Pharma Co., Ltd.6.4 Beijing
    Saike Pharmaceutical Co., Ltd.6.5 Guilin Winsun
    Pharmaceutical Co., Ltd.6.6 Changzhou Siyao
    Pharmaceutical Co., Ltd.6.7 Hainan Bright Future
    Pharmaceutical Co.,Ltd.6.8 Hainan Hualon
    Pharmaceutical Co., Ltd.
  • 7 Anallysis on Major Valsartan Manufacturers in
    China, 2009-2013
  • Complete report is available _at_ http//www.chinamar
    ketresearchreports.com/114712.html

6
Investigation Report on China Valsartan Market,
2009-2018
  • 7.1 Beijing Novartis7.2 Beijing Saike7.3
    Changzhou Siyao7.4 Hainan Hualon7.5 Lunan
    Better
  • 8 Prospect of China Valsartan Market,
    2014-20188.1 Forecast on Market Size8.2
    Forecast on Competition Pattern
  • List of Charts
  • Chart Valsartan Products Approved to Market in
    China, 2014Chart Forecast on Market Size of
    Hospital-use Valsartan in China, 2014-2018Chart
    Sales Value of Valsartan in Global Market,
    2009-2013Chart Sales Value of Valsartan in
    Hospital Market in China, 2009-2013Chart Sales
    Value of Valsartan by Region in China,
    2009-2013Chart Market Share of Valsartan
    Enterprises by Sales Value in China, 2009-2013
  • Inquire for discount _at_ http//www.chinamarketresea
    rchreports.com/contacts/inquiry.php?name114712
Write a Comment
User Comments (0)